Prevalence and risk factors of osteoporosis in female SLE patients - Extended report

Rheumatology

Volumn 46, Issue 7, 2007, Pages 1185-1190

  Almehed, Katarina ^a   Forsblad d', Elia H ^a   Kvist, G ^b   Ohlsson, C ^a   Carlsten, H ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Department of Rheumatology ^*  (Sweden)

Author keywords

Bone mineral density; Cross sectional study; Glucocorticosteroids; Osteoporosis; Risk factors; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CALCIUM; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; BODY WEIGHT; BONE DENSITY; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DISEASE MARKER; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HIP; HUMAN; KIDNEY DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MORBIDITY; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RADIUS; RISK ASSESSMENT; RISK FACTOR; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BODY MASS INDEX; BONE DENSITY; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CREATININE; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FEMALE; HUMANS; LINEAR MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK FACTORS;

EID: 34447342265     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem105     Document Type: Article

References (31)

1. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;7:407-13.
2. Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999;159:1215-20.
3. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet 1999;353:878-82.
4. Medeiros MM, Silveira VA, Menezes AP, Carvalho RC. Risk factors for ovarian failure in patients with systemic lupus erythematosus. Braz J Med Biol Res 2001;34:1561-8.
5. Buyon JP, Petri MA, Kim MY et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial. Ann Intern Med 2005;142:953-62.
6. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92:4-8.
7. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
8. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. 1995;54:274-6.
9. Coimbra IB, Costallat LT. Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset, plasmatic estradiol and immunosuppressive therapy. Joint Bone Spine 2003;70:40-5.
10. Yee CS, Crabtree N, Skan J et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 2005;64:111-3.
11. Gilboe IM, Kvien TK, Haugeberg G, Husby G. Bone mineral density in systemic lupus erythematosus: Comparison with rheumatoid arthritis and healthy controls. Ann Rheum Dis 2000;59:110-5.
12. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on prognosis studies in SLE. Arthritis Rheum 1992;35:630-40.
14. Gladman DD, Urowitz MB, Goldsmith CH et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
15. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.
16. Mazess RB, Hanson JA, Barden H. Lunar Corporation USA. Reference Data for DEXA. In: 12th International Body Density Workshop, Edinburgh, Scotland, 1997.
17. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 1997;24:1922-9.
18. Becker A, Fischer R, Scherbaum WA, Schneider M. Osteoporosis screening in systemic lupus erythematosus: Impact of disease duration and organ damage. Lupus 2001;10:809-14.
19. Sinigaglia L, Varenna M, Binelli L et al. Determinants of bone mass in systemic lupus erythematosus: A cross sectional study an premenopausal women. J Rheumatol 1999;26:1280-4.
20. Lee C, Almagor O, Dunlop DD et al. Disease damage and low bone mineral density: An analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology 2006;45:53-60.
21. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001;28:102-8.
22. Star VL, Hochberg MC. Osteoporosis in patients with rheumatic diseases. Rheum Dis Clin North Am 1994;20:561-76.
23. Pineau CA, Urowitz MB, Fortin PJ, Ibanez D, Gladman DD. Osteoporosis in systemic lupus erythematosus: Factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density. Lupus 2004;13:436-41.
24. Forsblad D'Elia H, Larsen A, Waltbrand E et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 2003;62:617-23.
25. Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone loss in patients with rheumatoid arthritis: Results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum 2002;46:1720-8.
26. Bultink IE, Lerns WF, Kostense PJ, Dijkmans BA, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:2044-50.
27. Hansen M, Halberg P, Kollerup G et al. Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. Scand J Rheumatol 1998;27:197-206.
28. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update.American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001;44:1496-503.
29. SBU. Osteoporos-prevention, diagnostik och behandling. Nr 165/1. Elanders graphic Systems, 2003.
30. Jardinet D, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, Houssiau FA. Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: Deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology 2000;39:389-92.
31. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82.